SG Americas Securities
ALBO

SG Americas Securities’s Albireo Pharma Inc ALBO Stock Holding History

SG Americas Securities’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-8,583
Closed -$166K – 3480
2022
Q3 		$166K Sell
8,583
-2,284
-21% -$47.2K ﹤0.01% 2469
2022
Q2 		$216K Buy
+10,867
New +$287K ﹤0.01% 2620
2021
Q4 		– Sell
-7,339
Closed -$229K – 3945
2021
Q3 		$229K Buy
+7,339
New +$227K ﹤0.01% 3138
2021
Q2 		– Sell
-3,277
Closed -$116K – 3360
2021
Q1 		$116K Buy
+3,277
New +$121K ﹤0.01% 3010
2020
Q3 		– Sell
-7,233
Closed -$192K – 3679
2020
Q2 		$192K Buy
+7,233
New +$171K ﹤0.01% 2893

Other funds holding ALBO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

SG Americas Securities's ALBO Position: Q4 2022 in Review

SG Americas Securities sold out of Albireo Pharma Inc (ALBO) in Q4 2022, closing a stake of 8,583 shares — an estimated $166K sold.

SG Americas Securities first reported a position in ALBO in Q2 2020 and held it in 5 quarters. The position peaked at $229K in Q3 2021. 96 funds tracked by Wall St. Rank hold ALBO as of Q4 2022.

  • SG Americas Securities reported no remaining Albireo Pharma Inc position as of Q4 2022 after selling out during the quarter.
  • SG Americas Securities sold 8,583 Albireo Pharma Inc shares in Q4 2022, an estimated $166K.
  • SG Americas Securities first reported a position in Albireo Pharma Inc in Q2 2020 and held it in 5 quarters.
  • SG Americas Securities's Albireo Pharma Inc position peaked at $229K in Q3 2021.
  • 96 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2022.

Based on SG Americas Securities's 13F filing for Q4 2022, filed 2 Feb 2023.